IS4556A - 17-díflúorómteýlen-östratríen - Google Patents

17-díflúorómteýlen-östratríen

Info

Publication number
IS4556A
IS4556A IS4556A IS4556A IS4556A IS 4556 A IS4556 A IS 4556A IS 4556 A IS4556 A IS 4556A IS 4556 A IS4556 A IS 4556A IS 4556 A IS4556 A IS 4556A
Authority
IS
Iceland
Prior art keywords
hydrogen atom
beta
alpha
östratríen
díflúorómteýlen
Prior art date
Application number
IS4556A
Other languages
English (en)
Inventor
Bohlmann Rolf
Rubanyl Gabor
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of IS4556A publication Critical patent/IS4556A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/02Halogenated hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Exhaust-Gas Circulating Devices (AREA)
  • Electrical Control Of Air Or Fuel Supplied To Internal-Combustion Engine (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Vehicle Body Suspensions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Ceramic Products (AREA)
IS4556A 1995-03-13 1997-09-08 17-díflúorómteýlen-östratríen IS4556A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19509729A DE19509729A1 (de) 1995-03-13 1995-03-13 17-Difluormethylen-Estratriene
PCT/EP1996/001069 WO1996028462A1 (de) 1995-03-13 1996-03-13 17-difluormethylen-estratriene

Publications (1)

Publication Number Publication Date
IS4556A true IS4556A (is) 1997-09-08

Family

ID=7756963

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4556A IS4556A (is) 1995-03-13 1997-09-08 17-díflúorómteýlen-östratríen

Country Status (21)

Country Link
US (2) US6018062A (is)
EP (1) EP0815120B1 (is)
JP (1) JPH11501644A (is)
KR (1) KR19980703002A (is)
AT (1) ATE199159T1 (is)
AU (1) AU693335B2 (is)
BR (1) BR9612787A (is)
CA (1) CA2215201A1 (is)
CZ (1) CZ281097A3 (is)
DE (2) DE19509729A1 (is)
HU (1) HUP9801846A3 (is)
IL (1) IL117497A (is)
IS (1) IS4556A (is)
NO (1) NO308306B1 (is)
PL (1) PL322199A1 (is)
RU (1) RU2155770C2 (is)
SI (1) SI9620030A (is)
SK (1) SK121697A3 (is)
TR (1) TR199700950T1 (is)
WO (1) WO1996028462A1 (is)
ZA (1) ZA962037B (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU703814B2 (en) * 1995-12-04 1999-04-01 Wyeth Antioxidant
US5773432A (en) * 1996-10-30 1998-06-30 Schering Aktiengesellschaft Method for lowering plasma levels of lipoprotein(a)
EP1654325A1 (en) * 2003-08-11 2006-05-10 Industria Chimica Reggiana I.C.R. S.P.A. Chemical composition and method of polymerisation thereof for use on vehicle bodywork repair
AU2005259499A1 (en) * 2004-06-29 2006-01-12 Jado Technologies Gmbh Use of steroid-derived pharmaceutical compositions for treating disorders relating to pathological processes in lipid rafts
US8030298B2 (en) 2005-05-26 2011-10-04 Abbott Products Gmbh 17β-HSD1 and STS inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3741800A1 (de) * 1987-12-07 1989-06-15 Schering Ag 17-halogenmethylen-estratriene
US5883087A (en) * 1991-01-07 1999-03-16 Pherin Corporation Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5783571A (en) * 1991-01-07 1998-07-21 Pherin Corporation Method of altering hypothalamic function by nasal administration of estrene steroids
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
US5773432A (en) * 1996-10-30 1998-06-30 Schering Aktiengesellschaft Method for lowering plasma levels of lipoprotein(a)

Also Published As

Publication number Publication date
NO308306B1 (no) 2000-08-28
ATE199159T1 (de) 2001-02-15
EP0815120B1 (de) 2001-02-14
PL322199A1 (en) 1998-01-19
DE59606435D1 (de) 2001-03-22
BR9612787A (pt) 1999-11-23
AU693335B2 (en) 1998-06-25
SI9620030A (sl) 1998-02-28
SK121697A3 (en) 1998-02-04
EP0815120A1 (de) 1998-01-07
WO1996028462A1 (de) 1996-09-19
NO974206L (no) 1997-11-13
RU2155770C2 (ru) 2000-09-10
AU5107896A (en) 1996-10-02
ZA962037B (en) 1996-09-25
US6136800A (en) 2000-10-24
NO974206D0 (no) 1997-09-12
US6018062A (en) 2000-01-25
IL117497A (en) 1999-12-22
HUP9801846A2 (hu) 1998-12-28
DE19509729A1 (de) 1996-09-19
HUP9801846A3 (en) 1999-03-01
MX9707006A (es) 1997-11-29
CZ281097A3 (cs) 1998-02-18
CA2215201A1 (en) 1996-09-19
TR199700950T1 (xx) 1998-02-21
KR19980703002A (ko) 1998-09-05
IL117497A0 (en) 1996-07-23
JPH11501644A (ja) 1999-02-09

Similar Documents

Publication Publication Date Title
NL350077I1 (nl) Cyprosulfamide
HUP0001192A2 (hu) Topiramát és származékainak alkalmazása elhízás kezelésére használható gyógyszerkészítmények előállítására
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
AR001440A1 (es) Nuevos taxoides, su preparación y composiciones farmacéuticas que los contienen.
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
ATE270817T1 (de) Fungizide
YU40997A (sh) Novi oksadiazoli, postupci za njihovo pripremanje
TR199701146T1 (xx) N�rotensin resept�rleri �zerinde etkili 1-Fenilpirazol-3-Karboksamidler.
DE69716292D1 (de) Benzopyranderivate
TR199701728T1 (xx) Sialil-Lewis X ve sialil-Lewis A taklitleri olarak digikosilatlanm�� 1,-2-dioller.
TR199701287T1 (xx) Azasikloalkan t�revleri, haz�rlan��lar� ve terapideki uygulamalar�.
DK0934080T3 (da) 1,3-Bis-(N-lactamyl)propaner og deres farmaceutiske og kosmetiske anvendelse
RS50229B (sr) Analozi vitamina d3
ATE338576T1 (de) Kosmetische zusammensetzungen
DK0852580T3 (da) Fremgangsmåde til fremstilling af dihydroxypyrimidin-derivater
DE59606435D1 (de) 17-difluormethylen-estratriene
TW350041B (en) Bis-depside tertiary alkyl ester derivatives and chemical positive photoresist material
TR199701298T1 (xx) Tetralinler.
BG101221A (bg) N-заместени азабициклохептанови производни, приложими като невролептици
TR199700802T2 (xx) Triazin t�revleri.
AR009105A1 (es) Derivados de n-(benzotiazol-2-il) piperidina-1-etanamina, su preparacion y aplicacion en terapeutica
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen
DK0788472T3 (da) Fremgangsmåde til fremstilling af 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalenderivater
ES2001102A6 (es) Un procedimiento para la preparacion de un derivado de indeno.